Inactive
Notice ID:SPE2D219R0044
Modification P00007 SPE2D220D0085 to exercise Option Year 4. Modification SPE2D220D0085 P00006 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. Modificati...
Modification P00007 SPE2D220D0085 to exercise Option Year 4. Modification SPE2D220D0085 P00006 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. Modification SPE2D220D0085 P00005 to incorporate clause FAR 52.204-27 Prohibition on a ByteDance Covered Application (JUN 2023) into subject contract. Modification P00004 SPE2D220D0085 to exercise Option 3. Modification P00003 SPE2D220D0085 to exercise Option 2. Modification P00002 SPE2D220D0085 to exercise Option 1. Modification P00001 SPE2D220D0085 to incorporate FAR 52.204-24 and FAR 52.204-25 into contract. Methylphenidate HCL ER